PAVmed Inc.
PAVM
$0.36
$0.011.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -99.28% | -73.36% | -33.92% | 22.15% | 166.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.28% | -73.36% | -33.92% | 22.15% | 166.27% |
| Cost of Revenue | -97.19% | -77.85% | -54.08% | -24.64% | -0.40% |
| Gross Profit | 93.62% | 83.64% | 70.08% | 53.54% | 51.80% |
| SG&A Expenses | -61.94% | -49.97% | -33.16% | -25.51% | -17.44% |
| Depreciation & Amortization | -100.00% | -94.49% | -90.09% | -72.33% | -47.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -66.14% | -55.96% | -42.11% | -33.36% | -23.96% |
| Operating Income | 63.74% | 54.85% | 42.50% | 35.34% | 27.70% |
| Income Before Tax | -85.52% | 193.89% | 186.77% | 135.86% | 111.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -85.52% | 193.89% | 186.77% | 135.86% | 111.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -88.48% | -68.16% | -40.39% | -24.69% | -8.73% |
| Net Income | -87.28% | 226.20% | 220.36% | 162.00% | 134.45% |
| EBIT | 63.74% | 54.85% | 42.50% | 35.34% | 27.70% |
| EBITDA | 62.78% | 53.64% | 40.91% | 34.28% | 27.34% |
| EPS Basic | -41.55% | 186.77% | 173.07% | 129.64% | 105.99% |
| Normalized Basic EPS | 93.44% | 85.22% | 75.29% | 67.60% | 45.65% |
| EPS Diluted | 83.78% | 112.60% | 106.37% | 74.23% | 58.82% |
| Normalized Diluted EPS | 97.23% | 96.14% | 84.61% | 74.02% | 50.37% |
| Average Basic Shares Outstanding | 79.35% | 58.38% | 40.87% | 33.77% | 32.38% |
| Average Diluted Shares Outstanding | 218.56% | 641.04% | 664.62% | 571.90% | 159.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |